Enfusion, Inc.

ENFNCIK 0001868912 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 21, 2025. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0039

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Apr 21, 2025no items parsed Apr 17, 2025no items parsed Apr 17, 2025no items parsed Apr 11, 2025no items parsed Apr 2, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Enfusion, Inc.

Name	Roles	Filings
Campobasso Matthew	Officer	10
Gutowski Valeria	Officer	10
Herring Bradley	Officer	9
Somers Deirdre	Director	9
Pawar Neal	Officer	8

Showing 6-10 of 34

Per pagePrevPage 2 of 7Next

All filings

151 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 6, 2025	Gutowski Valeria Chief Accounting Officer	SSale	1,233	$11.365	$14,013

Filed		Top transaction	Shares	Price	Value